CrossBride Bio is developing a dual-payload cancer drug expected to begin human trials in 2026. ・The U.S. Food and Drug ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts-including one oral presentation-for the ...
Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside ...
Clues to the genetic code’s origin may be hidden in tiny protein fragments, revealing a synchronized and highly structured ...
A graduate student at Fred Hutch Cancer Center has produced a near real-time picture of how well the human immune system is ...
Morning Overview on MSN
RNA that nearly self-replicates offers new clues to life’s origins
A strand of RNA just 45 nucleotides long can copy its own complementary sequence in frozen conditions that may resemble early Earth, according to a study published in Science in early 2026. The ...
his is what computer science looks like at its best — advancing discovery while improving lives on a global scale.
The RNA world hypothesis posits that molecules made up of ribonucleic acids (RNA) are responsible for kickstarting evolution ...
Scientists have identified a new RNA molecule that may play a key role in improving survival in cancer patients.
Cryo-EM reveals the first detailed structure of the Bornavirus nucleoprotein–RNA complex, uncovering unique RNA binding and assembly mechanisms.
CAMBRIDGE, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and ...
Cases of Borna disease virus 1 (BoDV-1) are extremely rare in humans, but in those who develop disease, the outcome is severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results